In today’s recent session, 0.42 million shares of the GeneDx Holdings Corp (NASDAQ:WGS) have been traded, and its beta is 2.14. Most recently the company’s share price was $73.39, and it changed around $4.96 or 7.25% from the last close, which brings the market valuation of the company to $1.87B. WGS at last check was trading at a discount to its 52-week high of $89.11, offering almost -21.42% off that amount. The share price’s 52-week low was $1.16, which indicates that the recent value has risen by an impressive 98.42% since then. We note from GeneDx Holdings Corp’s average daily trading volume that its 10-day average is 0.65 million shares, with the 3-month average coming to 561.80K.
GeneDx Holdings Corp stock received a consensus recommendation rating of Hold, based on a mean score of 2.00. If we narrow it down even further, the data shows that 0 out of 6 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 3 recommended WGS as a Hold, whereas 2 deemed it a Buy, and 0 rated it as Underweight. GeneDx Holdings Corp is expected to report earnings per share of 0.11 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
GeneDx Holdings Corp (NASDAQ:WGS) trade information
Instantly WGS has been showing a green trend so far today with a performance of 7.25% on intraday trading today. The rise to weekly highs of 82.18 on recent trading dayincreased the stock’s daily price by 10.7%. On the other hand, GeneDx Holdings Corp (NASDAQ:WGS) is 22.22% up in the 30-day period. We can see from the shorts that 2.6 million shares have been sold at a short interest cover period of 3.56 day(s).
The consensus price target as assigned by Wall Street analysts is $39.5, which translates to bulls needing to decrease their stock price by -85.8% from its current value. Analyst projections state that WGS is forecast to be at a low of $21 and a high of $70.
GeneDx Holdings Corp (WGS) estimates and forecasts
GeneDx Holdings Corp share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 237.27 percent over the past six months and at a 95.38% annual growth rate that is well above the industry average of 5.50%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will gain 116.95% in revenue this quarter, and will report an increase of 118.40% in the next quarter. The year-over-year growth rate is expected to be 42.27%, up from the previous year.
Consensus estimates provided by 6 financial analysts predict the company will bring in an average of 80.22M in revenue for the current quarter. 6 analysts expect GeneDx Holdings Corp to make 77.8M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 57.42M and 62.42M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 39.72%. Forecasts for the next quarter put sales growth at 24.63%.
WGS Dividends
GeneDx Holdings Corp’s next quarterly earnings report is expected to be released on 2025-Feb-18.
GeneDx Holdings Corp (NASDAQ:WGS)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 20.28% of GeneDx Holdings Corp shares, and 70.21% of them are in the hands of institutional investors. The stock currently has a share float of 88.07%.
